Fostering Science

Creating breakthrough medicines that change patients’ lives starts with a commitment to identify the health challenges of the future and advance emerging science. As an independent and family- owned company, we have the freedom to pursue our long- term vision, with distinctive approaches that enable new journeys of discovery today that will transform the lives of patients in generations to come.

On the search for groundbreaking trends
Frank Kalkbrenner
Fostering Science
The Boehringer Ingelheim Venture Fund (BIVF) acquires minority stakes in biotech start-ups exploring promising therapies and technologies, and even supports the majority before and during their founding.
Fostering Science

Find out more about partnering with us